Key facts
- This page summarizes Jonathan Dorfman's Form 3 filing for Teladoc Health, Inc. (TDOC).
- 0 reported transactions and 5 derivative rows are listed below.
- Accepted by SEC: 03 Nov 2026, 16:05.
Key filing fact
Ownership activity is grounded in SEC Form 3 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
No transaction description listed
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
No transaction description listed
No transaction description listed
No transaction description listed
No transaction description listed
No transaction description listed
Additional SEC filing notes
Footnote F1
On March 1, 2026, the reporting person earned 232 performance stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.
Footnote F2
Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
Footnote F3
On March 19, 2024, the reporting person was granted 10,000 restricted stock units, vesting one-third on March 19, 2025, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025.
Footnote F4
Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
Footnote F5
On March 1, 2025, the reporting person was granted 7,500 restricted stock units, vesting in full on March 1, 2028.
Footnote F6
On March 1, 2025, the reporting person was granted 10,000 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.
Footnote F7
On March 1, 2026, the reporting person was granted 10,00 restricted stock units, vesting one-third on March 1, 2027, with the remainder vesting in eight substantially equal quarterly installments thereafter.